Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease
2022
Vasundara Srinivasan | Hévila Brognaro | Prince R. Prabhu | Edmarcia Elisa de Souza | Sebastian Günther | Patrick Y. A. Reinke | Thomas J. Lane | Helen Ginn | Huijong Han | Wiebke Ewert | Janina Sprenger | Faisal H. M. Koua | Sven Falke | Nadine Werner | Hina Andaleeb | Najeeb Ullah | Bruno Alves Franca | Mengying Wang | Angélica Luana C. Barra | Markus Perbandt | Martin Schwinzer | Christina Schmidt | Lea Brings | Kristina Lorenzen | Robin Schubert | Rafael Rahal Guaragna Machado | Erika Donizette Candido | Danielle Bruna Leal Oliveira | Edison Luiz Durigon | Stephan Niebling | Angelica Struve Garcia | Oleksandr Yefanov | Julia Lieske | Luca Gelisio | Martin Domaracky | Philipp Middendorf | Michael Groessler | Fabian Trost | Marina Galchenkova | Aida Rahmani Mashhour | Sofiane Saouane | Johanna Hakanpää | Markus Wolf | Maria Garcia Alai | Dusan Turk | Arwen R. Pearson | Henry N. Chapman | Winfried Hinrichs | Carsten Wrenger | Alke Meents | Christian Betzel
Three natural phenolic compounds are found to bind to an allosteric site in SARS-CoV-2 papain-like protease and exhibit antiviral activity in vitro, showing potential as starting scaffolds for drug design.
Show more [+] Less [-]Bibliographic information
This bibliographic record has been provided by Directory of Open Access Journals
